¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"differentiation zone"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® differentiation ÇÑ±Û ºÐÈ­
¼³¸í   
  ¼¼Æ÷°¡ ºÐ¿­, Áõ½ÄÇÏ¿© ¼ºÀåÇϴ µ¿¾È¿¡ ±¸Á¶³ª ±â´ÉÀÌ ¼­·Î Æ¯¼öÈ­Çϴ Çö»ó. ´Ù¼¼Æ÷»ý¹° °³Ã¼¿¡¼­ ±â°üÀ̳ª Á¶Á÷À̳ª ¼¼Æ÷°£¿¡ ÇüÅÂÀû ¹× ±â´ÉÀû Â÷À̰¡ »ý±â°Ô µÇ´Âµ¥, ¿¹¸¦ µé¸é °³Ã¼¹ß»ý¿¡¼­ Ã³À½¿¡´Â µ¿ÁúÀ̾ú´ø ºÎºÐ¿¡¼­ ¸Ó¸®³ª ¸öÅë µîÀÇ ±¸º°ÀÌ »ý±â°í, ¼¼Æ÷¿¡¼­µµ ±Ù¼¼Æ÷, ½Å°æ¼¼Æ÷ µîÀÇ ±¸º°ÀÌ »ý±â´Â »óŸ¦ ¸»ÇÑ´Ù. ÀϹÝÀûÀ¸·Î ºÐÈ­ÇÑ ¼¼Æ÷¿¡¼­´Â ÇüÅÂÀû Æ¯¼öÈ­¿Í ´õºÒ¾î ºÐÈ­ÀÇ ÁöÇ¥°¡ µÇ´Â Æ¯ÀÌÇÑ ´Ü¹éÁú ÇÕ¼ºÀÌ ³ªÅ¸³ª±â ¶§¹®¿¡ ºÐÈ­´Â À¯ÀüÀÚÀÇ Á¶Àý¿¡ ÀÇÇØ ³ªÅ¸³­ °á°ú¶ó°í »ý°¢µÇ°í ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cluster of differentiation
    ºÐÈ­¹«¸®, ½Ãµð(CD)
  • differentiation
    ºÐÈ­
  • differentiation defect
    ºÐÈ­°áÇÔ
  • antibody excess zone
    Ç×ü°úÀ×±¸¿ª
  • antigen excess zone
    Ç׿ø°úÀ×±¸¿ª
  • border zone
    °æ°è±¸¿ª
  • coronal zone
    Ä¡¾Æ¸Ó¸®±¸¿ª, Ä¡°ü´ë
  • central zone
    Á߽ɱ¸¿ª
  • dolorogenic zone
    ÅëÁõ¹ß»ý´ë
  • equivalence zone
    ÇØ´ç·®±¸¿ª, ¸Â¸ÔÀ̱¸¿ª
  • erogenic zone
    ¼º°¨´ë
  • growth zone
    ¼ºÀ屸¿ª, ¼ºÀå´ë
  • high zone tolerance
    Ç׿ø°ú·®Çã¿ë
  • low-zone tolerance
    Ç׿ø¼Ò·®Çã¿ë
  • marginal zone
    °¡ÀåÀÚ¸®±¸¿ª, º¯¿¬´ë
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • differentiation
    ºÐÈ­
  • zone
    ±¸¿ª, ´ë, Ãþ
  • border zone
    °æ°è±¸¿ª
  • growth zone
    ¼ºÀ屸¿ª
  • reserve zone
    ¿¹ºñÃþ
  • transformation zone
    º¯ÇüÃþ
  • transitional zone
    ÀÌÇàºÎÀ§
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • differentiation
    ºÐÈ­
  • differentiation defect
    ºÐÈ­°áÇÔ
  • antibody excess zone
    Ç×ü°úÀ×±¸¿ª
  • antigen excess zone
    Ç׿ø°úÀ×±¸¿ª
  • border zone
    °æ°è±¸¿ª
  • central zone
    Á߽ɱ¸¿ª
  • chondrogenic zone
    ¿¬°ñÇü¼º±¸¿ª
  • coronal zone
    Ä¡°ü´ë, Ä¡¾Æ¸Ó¸®±¸¿ª
  • dendritic zone
    °¡Áöµ¹±âÁö¿ª
  • dolorogenic zone
    ÅëÁõ¹ß»ý´ë
  • dysacoustic zone
    ÀÌÀ½Çâ±Ç
  • equivalence zone
    ÇØ´ç·®±¸¿ª, ¸Â¸ÔÀ̱¸¿ª
  • erogenic zone
    ¼º°¨´ë
  • zone electrophoresis
    ±¸¿ªÀü±âÀ̵¿
  • glandular zone
    »ù±¸¿ª
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • B cell differentiation factor (BCDF)
    B¼¼Æ÷ ºÐÈ­À¯¹ßÀÎÀÚ
  • T-cell differentiation
    T-¼¼Æ÷ºÐÈ­
  • Cozzolinos zone
    âÀü¼Ò¿­.
  • Fraunhofer zone
    ÇÁ¶ó¿îÈ£ÆÛ À½¿ª
  • Frenel zone
    ÈÄ·¹³Ú À½¿ª
  • X zone
    X´ë.
  • acoustic zone
    À½Çâ´ë
  • adipose zone
    Áö¹æ±¸¿ª
  • alpine zone
    °í»ê´ë.
  • antibody excess zone
    Ç×ü°úÀ×´ë(ù÷ô÷Φí¥Óá).
  • antibody excess zone
    Ç×ü°úÀ×´ë(ù÷ô÷Φí¥Óá).
  • antibody excess zone
    Ç×ü°úÀ×´ë(ù÷ô÷Φí¥Óá).
  • antigen excess zone
    Ç׿ø°úÀ×´ë.
  • antigen excess zone
    Ç׿ø°úÀ×´ë.
  • antigen excess zone
    Ç׿ø°úÀ×´ë.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • differentiation zone
    ºÐÈ­±¸¿ª
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • erotogenic zone See erogenic zone
    ¼º°¨Á¶¼º´ë(àõÊïðãà÷Óá), »öÁ¤´ë(ßäï×Óá)
  • external zone peripheral zone
    ¹Ù±ùÃþ ÁÖº¯Ãþ
  • internal zone juxtamedullary zone
    ¼ÓÃþ ¼ÓÁú°çÃþ
  • opaque zone =turbid zone
    ºÒÅõ¸í ¿µ¿ª
  • cell differentiation
    ¼¼Æ÷ºÐÈ­(¡­ÝÂûù)
  • cell differentiation
    ¼¼Æ÷ºÐÈ­(¡­ÝÂûù).
  • differentiation
    °¨º°(Êüܬ), ºÐÈ­(ÝÂûù), ºÐº°(ÝÂܬ)
  • differentiation
    °¨º°(Êüܬ), ºÐÈ­(ÝÂûù), ºÐº°(ÝÂܬ).
  • differentiation
    ºÐÈ­
  • differentiation antigen
    °¨º°Ç׿ø(Êüܬù÷ê«)
  • differentiation defect
    ºÐÈ­°áÇÔ
  • differentiation factor
    °¨º°¿äÀÎ, °¨º°¿ä¼Ò, °¨º°ÀÎÀÚ
  • epidermal differentiation
    Ç¥ÇǺÐÈ­
  • lymphoid system differentiation
    ¸²ÇÁ°èºÐÈ­
  • regional differentiation
    ºÎÀ§Àû ºÐÈ­(Ý»êÈîÜÝÂûù)
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Differentiation zone
    ºÐÈ­±¸¿ª
    [¿¾ ¿ë¾î] ºÐÈ­´ë
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • External zone [Peripheral zone]
    ¹Ù±ùÃþ [ÁÖº¯Ãþ]
    [¿¾ ¿ë¾î] ¿Ü´ë
  • Internal zone [Juxtamedullary zone]
    ¼ÓÃþ [¼ÓÁú°çÃþ]
    [¿¾ ¿ë¾î] ³»´ë
  • Differentiation
    ºÐÈ­
    [¿¾ ¿ë¾î] ºÐÈ­
  • Differentiation defect
    ºÐÈ­°áÇÔ
    [¿¾ ¿ë¾î] ºÐÈ­°áÇÔ
  • Marginal zone
    °¡ÀåÀÚ¸®±¸¿ª
    [¿¾ ¿ë¾î] º¯¿¬´ë
  • External zone
    ¹Ù±ùÃþ
    [¿¾ ¿ë¾î] ¿Ü´ë
  • Segmental zone
    ºÐÀý±¸¿ª
    [¿¾ ¿ë¾î] (ºÐ)Àý±¸¿ª
  • Ossification zone
    »À¹ß»ýÃþ
    [¿¾ ¿ë¾î] °ñÈ­´ë
  • Glandular zone
    »ù±¸¿ª
    [¿¾ ¿ë¾î] ¼±´ë
  • Internal zone
    ¼ÓÃþ
    [¿¾ ¿ë¾î] ³»´ë
  • Reserve zone
    ¿¹ºñÃþ
    [¿¾ ¿ë¾î] ¿¹ºñ¿¬°ñ´ë
  • Peripheral zone
    ÁÖº¯±¸¿ª
    [¿¾ ¿ë¾î] ¸»ÃÊ´ë
  • Peripheral zone
    ÁÖº¯±¸¿ª
    [¿¾ ¿ë¾î] ÁÖº¯´ë
  • Intermediate zone
    Áß°£±¸¿ª
    [¿¾ ¿ë¾î] Áß°£´ë
  • Central zone
    Á߽ɱ¸¿ª
    [¿¾ ¿ë¾î] Á߽ɴë
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cell differentiation
    ¼¼Æ÷ºÐÈ­(á¬øàÝÂûù)
  • differentiation
    ºÐÈ­(ÝÂûù)
  • differentiation antigen
    ºÐÈ­ Ç׿ø(ÝÂûùù÷ê«)
  • antibody-excess zone
    Ç×ü°úÀ×±¸¿ª(ù÷ô÷Φí¥Ï¡æ´)
  • antigen-excess zone
    Ç׿ø°úÀ× ±¸¿ª(ù÷ê«Î¦í¥Ï¡æ´)
  • equivalence zone
    ´ç·®±¸¿ª(Ó×ÕáÏ¡æ´)
  • H zone
    H ¿ª(æ´)
  • inhibition zone
    ÀúÇØ¿ª(îÁúªæ´)
  • moving zone centrifugation
    À̵¿¿ª ¿ø½ÉºÐ¸®(ì¹ÔÑæ´êÀãýÝÂ×î)
  • multiphasic zone electrophoresis
    ´Ù»ó¿ªÀü±â¿µµ¿(ÒýßÒæ´ï³Ñ¨ç¶ÔÑ)
  • nuclear zone
    ÇÙ¿ª(ú·æ´)
  • overlapping zone
    Áßø¿ª(ñìôáæ´)
  • zone centrifugation
    ±¸¿ª(Ï¡æ´) ¿ø½ÉºÐ¸®(êÀãýÝÂ×î)
  • zone convection electrofocusing
    ±¸¿ª(Ï¡æ´) ´ë·ù(Óß×µ) Àü±â(ï³Ñ¨)Æ÷Ä¿½Ì
  • zone electromigration
    ±¸¿ª(Ï¡æ´) Àü±âÀ̵¿(ï³Ñ¨ì¹ÔÑ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • opaque zone =turbid zone
    ºÒÅõ¸í¿µ¿ª
  • differentiation
    °¨º°, ÁØÈ­, ºÐº°
  • dead zone
    »ç°¢Áö´ë
  • focal zone
    ÃÊÁ¡¿µ¿ª
  • Fraunhofer zone
    ÇÁ¶ó¿îÈ£ÆÛÀ½¿ª
  • free zone
    ÀÚÀ¯¿µ¿ª, ºó¿µ¿ª
  • Frenel zone
    ÈÄ·¹³Ú À½¿ª
  • interface zone
    °è¸é±¸¿ª
  • mantle zone
    ¿ÜÅõ´ë
  • radiolucent zone
    ¹æ»ç¼±Åõ°ú ¿µ¿ª
  • zone
    ±¸¿ª, Ãæ, ´ë
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AML Acute Myelogenous Leukemia
  Morphologic Classification(FABºÐ·ù)
   &n...
EDF eosinophil differentiation factor; erythroid differentiation factor; extradural fluid
FAZ Fanconi-Albertini-Zellweger [syndrome]; foveal avascular zone; fragmented atrial activity zone
PZ pancreozymin; pregnancy zone; proliferative zone; protamine zinc
CD Cluster of differentiation
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
EDF A/erythroid differentiation factor
ADRP Adipose differentiation related protein
BCDF B cell differentiation factor
CD Cluster of Differentiation
CMD Corticomedullary differentiation
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • cell differentiation
    ¼¼Æ÷ ºÐÈ­
    ¼¼Æ÷µéÀÌ Á¶Á÷ÀÇ ´Ù¾çÇÑ ±âº» ¼¼Æ÷ ´ÜÀ§·Î ¼ºÀåÇÏ´Â °Í. »óÇǼ¼Æ÷, ½Å°æ¼¼Æ÷
  • differentiation antigen
    ºÐÈ­ Ç׿ø
    ¼¼Æ÷°¡ ºÐÈ­ÇØ °¡´Âµ¥ À־ Ç¥ÇöµÇ´Â ¼¼Æ÷¸· »óÀÇ Ç׿ø. T ¼¼Æ÷¿¡¼­´Â B ¼¼Æ÷·ÎºÎÅÍ ±¸º°ÇÏ´Â ºÐÈ­ Ç׿øÀº mouse »çÀÌ¿¡¼­ ¼¼Æ÷¸¦ Åõ¿©ÇÏ¿© ¸¸µé¾îÁø µ¿Á¾ Ç×Ç÷û¿¡ ÀÇÇÏ¿© °ËÃâµÇ´Â Ç׿ø
  • differentiation factor
    °¨º° ¿äÀÎ, °¨º° ¿ä¼Ò, °¨º° ÀÎÀÚ
  • sex differentiation
    ¼º ºÐÈ­
  • squamous differentiation
    ÆíÆò »óÇÇ·ÎÀÇ ºÐÈ­
  • adipose zone
    Áö¹æ ±¸¿ª
  • antibody excess zone
    Ç×ü °úÀ׿ª
  • articular zone
    °üÀý ¿µ¿ª
  • calcified cartilage zone
    ¼®È¸È­µÈ ¿¬°ñ ºÎÀ§
    Ȱ¾× °üÀý¿¡¼­ °üÀýÀÇ ¿¬ Á¶Á÷°ú ¿¬°ñÇÏ °ñ
  • chemoreceptor trigger zone
    È­ÇÐ °¨¼öü À¯¹ß Áö¿ª
  • climatic zone
    ±âÈÄ ´ë
  • comfort zone
    Äè°¨´ë
  • condensation zone
    ÀÀÃà´ë
  • dorsal root entry zone

    dorsal root ganglion (¹è±Ù ½Å°æÀý, Èı٠½Å°æÀý

  • erogenic zone
    ¼º°¨ Á¶¼º´ë
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
antigens, differentiation Antigens expressed primarily on the membranes of living cells during sequential stages of maturation and differentiation. As immunologic markers they have high organ and tissue specificity and are useful as probes in studies of normal cell development as well as neoplastic transformation.
(12 Dec 1998)
antigens, differentiation, b-lymphocyte Membrane antigens associated with maturation stages of B-lymphocytes, often expressed in tumours of B-cell origin.
(12 Dec 1998)
antigens, differentiation, myelomonocytic Surface antigens expressed on myeloid cells of the granulocyte-monocyte-histiocyte series during differentiation. Analysis of their reactivity in normal and malignant myelomonocytic cells is useful in identifying and classifying human leukaemias and lymphomas.
(12 Dec 1998)
antigens, differentiation, t-lymphocyte Antigens expressed on the cell membrane of T-lymphocytes during differentiation, activation, and normal and neoplastic transformation. Their phenotypic characterization is important in differential diagnosis and studies of thymic ontogeny and T-cell function.
(12 Dec 1998)
B-cell differentiation/growth factors Various substances, usually obtained from the supernatant of T-cell cultures, such as interleukin 4, 5, and 6. These substances are necessary for B-cell growth, maturation, and differentiation into plasma cells or B memory cells.
(05 Mar 2000)
cell differentiation Progressive restriction of the developmental potential and increasing specialization of function which takes place during the development of the embryo and leads to the formation of specialised cells, tissues, and organs.
(12 Dec 1998)
cluster of differentiation Cell membrane molecules that are used to classify leukocytes into subsets. CD molecules are classified by monoclonal antibodies.
(05 Mar 2000)
cluster of differentiation 2 A glycoprotein that is expressed on all peripheral T-cells, large granular lymphocytes and most, but not all, thymocytes. CD2 is involved in signal transduction and cell adhesion.
(05 Mar 2000)
cluster of differentiation 3 A complex of 5 polypeptides associated with the T-cell receptor and is involved in signal transduction.
(05 Mar 2000)
cluster of differentiation 4 A glycoprotein found on various subsets of T-cells, i.e., usually no helper and some T cytotoxic cells.
(05 Mar 2000)
cluster of differentiation 8 Membrane glycoprotein found on subsets of T lymphocytes. CD8 is expressed on T cytotoxic cells and T suppressor cells.
Acronym: CD
(05 Mar 2000)
correlative differentiation Differentiation due to the interaction of different parts of an organism.
(05 Mar 2000)
self-differentiation Differentiation resulting from the action of intrinsic causes.
(05 Mar 2000)
sex differentiation Differentiation of male and female tissues and organs during embryogenesis, but after sex determination (sex determination (genetic)).
(12 Dec 1998)
sex differentiation disorders Disorders in the differentiation process of gonadal tissues and organs during embryogenesis.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • differentiation
    ±¸º°;ºÐÈ­;º¯ÀÌ;Ư¼öÈ­;¹ÌºÐ
  • zone
    Áö¿ª
  • Arctic Zone
    ºÏ±Ø´ë
  • Canal Zone
    ÆÄ³ª¸¶ ¿îÇÏ Áö´ë(2000³â¿¡ ¹Ì±¹ÀÌ ÆÄ³ª¸¶¿¡ ¹Ýȯ ¿¹Á¤)
  • Frigid Zone
    ÇÑ´ë
  • Temperate Zone
    the ¿Â´ë
  • Torrid Zone
    the ¿­´ë
  • communications zone
    º´Âü °ü±¸(Áö´ë)
  • danger zone
    (±º)À§Çè Áö´ë
  • demilitarized zone
    ºñ¹«ÀåÁö´ë(¾à DMZ)
  • drop zone
    (±º)(³«ÇÏ»ê)ÅõÇÏ(°­ÇÏ)Áö¿ª
  • economic development zone
    (Áß°øÀÇ)°æÁ¦ °³¹ß±¸
  • economic zone
    °æÁ¦ ¼ö¿ª
  • end zone
    ¿£µå Á¸(°ñ¶óÀΰú ¿£µå¶óÀÎ »çÀÌÀÇ ±¸¿ª)
  • enterprise zone
    (ÇàÁ¤)»ç¾÷ Áö¿ª;±â¾÷Áö±¸;±âȹ »ç¾÷ Áö´ë
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á